Imaging medication pre-treatment withheld name : FITBIR : Federal Interagency Traumatic Brain Injury Research Informatics System

Listed below are the details for the data element.

Version

1.6

Element Type

Common Data Element

Title

Imaging medication pre-treatment withheld name

Variable Name

ImgMedctnPrtrtmntWithhldName

Short Description

Medication pre-treatment withheld name

Definition

Name of the pre-treatment withheld agent or drug

Biomedical Terminologies and Standards

Notes

Data Sharing Instructions: The verbatim name (generic or trade name) of the medication should be collected. However, prior to aggregation or sharing the medication names should be coded using the RxNorm atom unique identifier (RXAUI).

Creation Date

Historical Notes

References

RXNorm (http://www.nlm.nih.gov/research/umls/rxnorm/); NCI Common Data Element Browser Public ID = 3162728

Data Type

Alphanumeric

Input Restrictions

Free-Form Entry

Maximum Character Quantity

4000

External Schema Permissible Value Mapping

Population

Adult and Pediatric

Guidelines/Instructions

Record the verbatim name (generic or trade name) of the medication the participant/subject reports taking. Add date stamp for when assessed. For TBI studies recommend collection is at least on date of TBI.

Preferred Question Text

Category Groups and Classifications

Disease	Domain	Sub-Domain
Traumatic Brain Injury	Assessments and Examinations	Imaging Diagnostics
General (For all diseases)	Assessments and Examinations	Imaging Diagnostics
Parkinson's Disease	Assessments and Examinations	Imaging Diagnostics

Classification

Parkinson's Disease :

Supplemental

General (For all diseases) :

Supplemental

Epidemiology :

Supplemental

Moderate/Severe TBI: Rehabilitation :

Supplemental

Acute Hospitalized :

Supplemental

Concussion/Mild TBI :

Supplemental

Keywords

MEG , Imaging_MEG

Labels

Effective Date

Until Date

Last Change Date

Mon Jan 16 12:36:14 EST 2023

Change History